AR046400A1 - Sales de pantoprazol - Google Patents

Sales de pantoprazol

Info

Publication number
AR046400A1
AR046400A1 ARP040102594A ARP040102594A AR046400A1 AR 046400 A1 AR046400 A1 AR 046400A1 AR P040102594 A ARP040102594 A AR P040102594A AR P040102594 A ARP040102594 A AR P040102594A AR 046400 A1 AR046400 A1 AR 046400A1
Authority
AR
Argentina
Prior art keywords
salts
pantoprazol
ion
ylmethylsulfinyl
counterbalanced
Prior art date
Application number
ARP040102594A
Other languages
English (en)
Inventor
Bernhard Kohl
B Muller
Ernst Sturm
Rolf-Peter Hummel
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of AR046400A1 publication Critical patent/AR046400A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Sales metálicas farmacológicamente compatibles de piridin-2-ilmetilsulfinil-1H-benzimidazoles con actividad inhibitoria de H+/K+-ATPasa, caracterizadas porque al menos un equivalente de carga positiva del ión metálico está contrabalanceado por un ión hidroxilo, e hidratos de las mismas.
ARP040102594A 2003-07-23 2004-07-22 Sales de pantoprazol AR046400A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03016760 2003-07-23
EP03016759 2003-07-23

Publications (1)

Publication Number Publication Date
AR046400A1 true AR046400A1 (es) 2005-12-07

Family

ID=34117526

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102594A AR046400A1 (es) 2003-07-23 2004-07-22 Sales de pantoprazol

Country Status (18)

Country Link
US (1) US20060189590A1 (es)
EP (1) EP1651217B1 (es)
JP (1) JP2006528158A (es)
AR (1) AR046400A1 (es)
AT (1) ATE386522T1 (es)
AU (1) AU2004260832A1 (es)
CA (1) CA2532774A1 (es)
DE (1) DE602004011946T2 (es)
DK (1) DK1651217T3 (es)
ES (1) ES2302007T3 (es)
HR (1) HRP20080191T3 (es)
IL (1) IL172600A0 (es)
MX (1) MXPA06000652A (es)
PL (1) PL1651217T3 (es)
PT (1) PT1651217E (es)
SI (1) SI1651217T1 (es)
TW (1) TW200509921A (es)
WO (1) WO2005011692A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510849A1 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
JP5017274B2 (ja) * 2005-10-26 2012-09-05 ハンミ・サイエンス・カンパニー・リミテッド Ｓ−オメプラゾールストロンチウム塩またはその水和物、その製造方法、及びこれを含む医薬組成物
PL1976532T3 (pl) 2006-01-27 2016-05-31 Univ Yale Szybko działający inhibitor wydzielania kwasu żołądkowego
US8512761B2 (en) 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
US8264615B2 (en) 2008-06-19 2012-09-11 Marvell World Trade Ltd. Split edge enhancement architecture
CN102336788B (zh) * 2011-06-29 2014-08-27 涂家生 质子泵抑制剂氨基葡萄糖复盐

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPH08509738A (ja) * 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド 光学的に純粋な（＋）パントプラゾールを用いる胃の疾患治療の方法と組成
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
DE10061137B4 (de) * 2000-12-07 2016-10-06 Takeda Gmbh Neue pharmazeutische Zubereitung

Also Published As

Publication number Publication date
PT1651217E (pt) 2008-05-23
DE602004011946D1 (de) 2008-04-03
AU2004260832A1 (en) 2005-02-10
EP1651217B1 (en) 2008-02-20
ES2302007T3 (es) 2008-07-01
DE602004011946T2 (de) 2009-03-19
DK1651217T3 (da) 2008-06-16
EP1651217A1 (en) 2006-05-03
CA2532774A1 (en) 2005-02-10
PL1651217T3 (pl) 2008-07-31
HRP20080191T3 (en) 2008-05-31
IL172600A0 (en) 2006-04-10
ATE386522T1 (de) 2008-03-15
TW200509921A (en) 2005-03-16
US20060189590A1 (en) 2006-08-24
SI1651217T1 (sl) 2008-08-31
JP2006528158A (ja) 2006-12-14
WO2005011692A1 (en) 2005-02-10
MXPA06000652A (es) 2006-03-30

Similar Documents

Publication Publication Date Title
UA85559C2 (en) Aminobenzophenone compounds
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
DE602004019855D1 (de) Sicherheitsüberwacher für einen am Telefon angebrachten Hilfsrechner
MX337081B (es) Anticuerpo anti-nr10 y su uso.
DE602004024037D1 (de) Substituierte heterozyklen
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
NO20084024L (no) Imidazolbaserte forbindelser, preparater omfattende slike, og anvendelse av slike
CR9068A (es) Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero
ATE400319T1 (de) Tetrahydropyridothiophene
AR046400A1 (es) Sales de pantoprazol
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
EA200100963A1 (ru) Средство для лечения артрита
UY28344A1 (es) Nuevos compuestos
EP1474396A4 (en) N-SUBSTITUTE3-HYDROXY-4-PYRIDINONES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
CA109514S (en) Door facing
NO20053562L (no) Nye aminobenzofenonforbindelser
HRP20080179T3 (en) Novel imidazopyridine compound ii with therapeutic effect
RU2005128402A (ru) Способ определения биологического возраста человека
ATE495148T1 (de) Die produktion von tnf-alpha inhibierenden 2- cyclopenten-1-onoximderivate
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
DE602004017231D1 (de) Immunmodulierende oxopyrazolocinnoline als cd80-inhibitoren
ATE348803T1 (de) Tryptase-inhibitoren
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase

Legal Events

Date Code Title Description
FA Abandonment or withdrawal